Impact of dialysis dependence on survival for multiple myeloma with renal impairment: a multicenter study in China

• Published in: American journal of cancer research Vol. 13; no. 4; pp. 1571 - 1581
• Main Authors: Jian, Yuan, Zhou, Huixing, Xie, Weiwei, Ren, Yuan, Zhang, Zhiyao, Yang, Guangzhong, Geng, Chuanying, Jia, Jing, Chen, Wenming, Huang, Wenrong, Cen, Xinan, Gao, Wen
• Format: Journal Article
• Language: English
• Published: United States e-Century Publishing Corporation 01.01.2023
• Subjects: Original; dialysis dependence; dialysis independence; Multiple myeloma; survival; renal impairment
• ISSN: 2156-6976; 2156-6976

Renal impairment (RI) is a very common complication of multiple myeloma (MM) with a negative impact on survival. Herein we retrospectively analyzed 334 MM patients with renal impairment at diagnosis from three hospitals in China. All 334 patients were divided into three groups, including dialysis dependence (n=43), dialysis independence (n=42), and without dialysis (n=249). Compared with dialysis independence and without dialysis groups, dialysis dependence group had the lowest overall hematologic response (48.8% vs. 97.6% vs. 77.1%, P<0.001) and overall renal response (0.0% vs. 97.6% vs. 72.7%, P<0.001), as well as the highest early mortality within 24 months (50.0% vs. 24.4% vs. 26.3%, P=0.006). Dialysis dependence group had similar progression-free survival (24 vs. 26 vs. 27 months, P=0.231) and significantly shorter overall survival (25 vs. 69 vs. 45 months, P=0.001). Dialysis dependence was independently associated with high mortality within 24 months and shorter overall survival. In conclusion, MM patients with dialysis dependence still tend to suffer a dismal disease course, including a high probability to suffer early mortality, worse hematological and renal response, as well as shorter survival. Dialysis independence could be very promising for survival improvement.